 Cytotoxic chemotherapy induces differentiation small-cell lung carcinoma high response rates chemotherapy majority small-cell lung cancer SCLC patients chemoresistant tumors phenotypic changes precursors chemoresistant status role chemotherapy changes tumor samples patients chemotherapy etoposide doxorubicin cyclophosphamide onset chemoresistance courses chemotherapy histologic changes minor patients increase cell size major patients appearance mixed composite tumors neuroendocrine NE epidermoid glandular components mixed Major changes good response Ultrastructural studies increase neurosecretory granules desmosomes high frequency multidirectional differentiation comparison pretherapy samples Immunohistochemical IH analysis increase cytokeratin CK expression treated patients different labeling pattern expression molecular weight CK expression NE lineage markers Leu Sy SL stable NE differentiation markers Leu chromogranin treated patients neuron-specific enolase NSE activity stable treated SCLC Large cells differentiated phenotype proliferative capacity Ki labeling characteristic treated secondary chemoresistant SCLC acquisition complex phenotype primary response drug-induced differentiation SCLC